Literature DB >> 15065885

The time-dependent distribution of phosphorylated intermediates in native sarcoplasmic reticulum Ca2+-ATPase from skeletal muscle is not compatible with a linear kinetic model.

James E Mahaney1, David D Thomas, Jeffrey P Froehlich.   

Abstract

Quenched-flow mixing was used to characterize the kinetic behavior of the intermediate reactions of the skeletal muscle sarcoplasmic reticulum (SR) Ca-ATPase (SERCA1) at 2 and 21 degrees C. At 2 degrees C, phosphorylation of SR Ca-ATPase with 100 microM ATP labeled one-half of the catalytic sites with a biphasic time dependence [Mahaney, J. E., Froehlich, J. P., and Thomas, D. D. (1995) Biochemistry 34, 4864-4879]. Chasing the phosphoenzyme (EP) with 1.66 mM ADP 10 ms after the start of phosphorylation revealed mostly ADP-insensitive E2P (95% of EP(total)), consistent with its rapid formation from ADP-sensitive E1P. The consecutive relationship of the phosphorylated intermediates predicts a decrease in the proportion of E1P ([E1P]/[EP(total)]) with increasing phosphorylation time. Instead, after 10 ms the proportion of E1P increased and that of E2P decreased until they reached a constant 1:1 stoichiometry ([E1P]:[E2P] approximately 1). At 21 degrees C, phosphorylation displayed a transient overshoot associated with an inorganic phosphate (P(i)) burst, reflecting increased turnover of E2P at the higher temperature. The P(i) burst exceeded the decay of the EP overshoot, suggesting that rephosphorylation of the enzyme occurs before the recycling step (E2 --> E1). This behavior and the reversed order of accumulation of phosphorylated intermediates at 2 degrees C are not compatible with the conventional linear consecutive reaction mechanism: E1 + ATP --> E1.ATP --> E1P + ADP --> E2P --> E2.P(i) --> E1 + P(i). Solubilization of the Ca-ATPase into monomers using the nonionic detergent C(12)E(8) gave a pattern of phosphorylation in which E1P and E2P behave like consecutive intermediates. Kinetic modeling of the C(12)E(8)-solubilized SR Ca-ATPase showed that it behaves according to the conventional Ca-ATPase reaction mechanism, consistent with monomeric catalytic function. We conclude that the nonconforming features of native SERCA1 arise from oligomeric protein conformational interactions that constrain the subunits to a staggered or out-of-phase mode of operation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15065885     DOI: 10.1021/bi035068g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Intermolecular interactions in the mechanism of skeletal muscle sarcoplasmic reticulum Ca(2+)-ATPase (SERCA1): evidence for a triprotomer.

Authors:  James E Mahaney; David D Thomas; Iain K Farrance; Jeffrey P Froehlich
Journal:  Biochemistry       Date:  2008-12-23       Impact factor: 3.162

Review 2.  Mechanism of allosteric effects of ATP on the kinetics of P-type ATPases.

Authors:  Ronald James Clarke
Journal:  Eur Biophys J       Date:  2009-02-19       Impact factor: 1.733

3.  Active detergent-solubilized H+,K+-ATPase is a monomer.

Authors:  Ingrid Dach; Claus Olesen; Luca Signor; Poul Nissen; Marc le Maire; Jesper V Møller; Christine Ebel
Journal:  J Biol Chem       Date:  2012-10-10       Impact factor: 5.157

4.  Dynamics of P-type ATPase transport revealed by single-molecule FRET.

Authors:  Mateusz Dyla; Daniel S Terry; Magnus Kjaergaard; Thomas L-M Sørensen; Jacob Lauwring Andersen; Jens P Andersen; Charlotte Rohde Knudsen; Roger B Altman; Poul Nissen; Scott C Blanchard
Journal:  Nature       Date:  2017-11-08       Impact factor: 49.962

5.  Phospholamban modulates the functional coupling between nucleotide domains in Ca-ATPase oligomeric complexes in cardiac sarcoplasmic reticulum.

Authors:  Linda T L Chen; Qing Yao; Thereza A Soares; Thomas C Squier; Diana J Bigelow
Journal:  Biochemistry       Date:  2009-03-24       Impact factor: 3.162

Review 6.  Single-Molecule FRET of Membrane Transport Proteins.

Authors:  Kim Bartels; Tanya Lasitza-Male; Hagen Hofmann; Christian Löw
Journal:  Chembiochem       Date:  2021-05-21       Impact factor: 3.164

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.